Modulation of cardiac and hepatic cytochrome P450 enzymes during heart failure.
about
The innate immune response to coxsackievirus B3 predicts progression to cardiovascular disease and heart failure in male miceHepatic cytochrome P450 enzyme alterations in humans with progressive stages of nonalcoholic fatty liver diseaseThe Role of Oxygen Sensors, Hydroxylases, and HIF in Cardiac Function and DiseaseEpoxides and soluble epoxide hydrolase in cardiovascular physiologyGene-gene interaction between PPARG and CYP1A1 gene on coronary artery disease in the Chinese Han PopulationMitochondrial activity and oxidative stress functions are influenced by the activation of AhR-induced CYP1A1 overexpression in cardiomyocytes.Aspirin treatment of mice infected with Trypanosoma cruzi and implications for the pathogenesis of Chagas diseaseHemoglobin regulates the metabolic, synthetic, detoxification, and biotransformation functions of hepatoma cells cultured in a hollow fiber bioreactor.The association between CYP1A1 genetic polymorphisms and coronary artery disease in the Uygur and Han of ChinaSoluble epoxide hydrolase inhibitor, TUPS, protects against isoprenaline-induced cardiac hypertrophy.Eicosanoid signalling pathways in the heart.Molecular mechanisms and cell signaling of 20-hydroxyeicosatetraenoic acid in vascular pathophysiology.Sex-dependent alteration of cardiac cytochrome P450 gene expression by doxorubicin in C57Bl/6 mice.Role of cytochrome P450-mediated arachidonic acid metabolites in the pathogenesis of cardiac hypertrophy.Clinical pharmacokinetics of drugs in patients with heart failure: an update (part 2, drugs administered orally).Developmental and extracellular matrix-remodeling processes in rosiglitazone-exposed neonatal rat cardiomyocytes.Contextualizing Genetics for Regional Heart Failure CareFluvoxamine pharmacokinetics in healthy elderly subjects and elderly patients with chronic heart failure.The Physiopathology of Cardiorenal Syndrome: A Review of the Potential Contributions of Inflammation.Endothelin-1-induced hypertrophic alterations and heme oxygenase-1 expression in cardiomyoblasts are counteracted by beta estradiol: in vitro and in vivo studies.Maternal high-fat diet associated with altered gene expression, DNA methylation, and obesity risk in mouse offspring.Heart failure and adverse drug reactions among hospitalized older adults.Impact of interaction between CYP1A1 genetic polymorphisms and smoking on coronary artery disease in the Han of China.A GENS-based approach to cardiovascular pharmacology: impact on metabolism, pharmacokinetics and pharmacodynamics
P2860
Q21195890-6C49C161-1A22-486B-9EA1-75FB7F3F07E6Q24319917-14F334F2-C3EE-472C-A31F-CB4F41441687Q26780548-91F6FC09-6C8E-41A8-BCB1-7A4C8AC23468Q28396313-3F0EFC66-26C1-45E0-9DA2-30C163F16EA3Q33798385-F4151597-8964-4DC8-BAA5-D954C299745EQ33828175-47972BE8-DF18-49AB-AACE-701A34EA348EQ33828299-43FDD7CA-7FD4-4B8A-91E1-A4ECF80665E8Q34163147-A991132A-C2EE-4287-871A-990E75265A3EQ34246447-563A13C6-981A-4423-90DA-E75A1B18817BQ36756985-55198ECD-0539-4DE5-8C86-0051EC508F5DQ37176175-49CA4511-3C24-4CFA-AF48-8FCF5F930EECQ37340856-F4AD96E5-9C0B-4281-9574-AF734F1E3F5AQ37569491-7C0D2F9F-C12A-420E-A2DA-52119C48D6F6Q38100223-9DD1390A-7F27-4A27-AD41-BABC544345D1Q38253565-780618B1-F879-4FD9-9AC9-ED437233985BQ38476306-A872DCD3-0CD9-45D2-B15E-C4E293B1863EQ38859880-B9BDEF8F-441D-4A27-BFB2-C3C4FAE004DDQ39317953-872C471F-559F-4B17-B580-8C55E50A6391Q48172048-6AE1AB90-A19A-49BE-8419-3B1A476C1196Q49887539-32B76E0B-D425-4361-B5AC-09CC97677AE2Q49980071-E00B1A8E-E18A-4D40-A708-380FEC3D1005Q51632780-02EE2360-8574-4CEE-9F73-3AD8B2A7B34AQ53494277-EECBFFD4-DED1-4E1F-912B-F8DE1A1017D0Q58294605-7C4F1632-239B-4979-871C-CAD88BA3FBBD
P2860
Modulation of cardiac and hepatic cytochrome P450 enzymes during heart failure.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Modulation of cardiac and hepatic cytochrome P450 enzymes during heart failure.
@en
Modulation of cardiac and hepatic cytochrome P450 enzymes during heart failure.
@nl
type
label
Modulation of cardiac and hepatic cytochrome P450 enzymes during heart failure.
@en
Modulation of cardiac and hepatic cytochrome P450 enzymes during heart failure.
@nl
prefLabel
Modulation of cardiac and hepatic cytochrome P450 enzymes during heart failure.
@en
Modulation of cardiac and hepatic cytochrome P450 enzymes during heart failure.
@nl
P1476
Modulation of cardiac and hepatic cytochrome P450 enzymes during heart failure
@en
P2093
Ayman O S El-Kadi
P304
P356
10.2174/138920008783571792
P407
P577
2008-02-01T00:00:00Z